Popular topics
Health technology, digital therapeutics, biotech, and the slow remaking of medical practice through software and devices.
705 articles · Health Tech & Medtech
Delft-based OASYS NOW, the EU's first AI-powered patient recruitment platform, has been announced as the winner of Slush 100 after pitching live on the international summit’s Startup Stage.
Oulu, Finland-based ŌURA, a maker of the smart ring, on Tuesday, November 19, announced that it has secured $75M (approximately €71M) in a Series D funding round at a valuation of $5B (approximately €4.7B) from California-based DexCom, a company specialised in glucose biosensing.
London-based Heim Health (formerly known as Ally Health), a healthcare company that provides on-demand clinical care, announced on Tuesday that it has secured €2.65M in a seed funding round.
Berlin-based Quantune, a deep tech startup in optics and photonics technology, announced on Tuesday that it has secured €13.5M in seed financing round.
Delft-based uPATCH, a health-tech startup, has secured seed funding from INZET, a fund managed by Shaping Impact Group, to further its mission of advancing global drug delivery through microneedle technology.
Lund, Sweden-based Aligned Bio, a nanotechnology company, announced on Monday that it has secured SEK 19.4M (approximately €1.6M) in…
Amsterdam-based Confocal.nl, a microscope manufacturer, announced on Thursday that it has secured €5M from a consortium of investors…
Rotterdam-based Kaminari Medical, a medtech company specialised in intravascular imaging technology, announced on Monday that it has secured €3.8M in a fresh funding round.
Amsterdam-based LUMICKS, a life science tools company, announced on Thursday that it has secured €20M in venture debt agreement from the European Investment Bank (EIB).
Paris-based Generare, a biotech company, announced on Tuesday that it has secured €5M in Seed funding from Teampact.ventures, Galion.Exe, and EU-backed VIVES Partners.
Vienna-based Flinn.ai, a startup that automates and optimises compliance processes for medtech companies, has secured €6M in seed round funding.
Lyon, France-based Brenus Pharma, a biotech company specialising in developing cancer vaccines, announced on Wednesday that it has secured €22.2M in a Series A funding round.
